北大医药
(000788)
| 流通市值：32.12亿 | | | 总市值：32.12亿 |
| 流通股本：5.96亿 | | | 总股本：5.96亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 493,957,274.92 | 2,193,796,738.18 | 1,655,471,575.84 | 1,083,854,155.88 |
| 营业收入 | 493,957,274.92 | 2,193,796,738.18 | 1,655,471,575.84 | 1,083,854,155.88 |
| 二、营业总成本 | 442,875,679.72 | 2,100,359,322.43 | 1,591,060,483.98 | 1,035,365,755.56 |
| 营业成本 | 344,356,273 | 1,481,856,314.07 | 1,105,890,776.61 | 711,144,964.23 |
| 税金及附加 | 2,699,338.28 | 12,730,412.54 | 9,620,511.24 | 6,092,364.67 |
| 销售费用 | 72,711,913.36 | 459,836,159.36 | 375,308,418.61 | 254,007,970.36 |
| 管理费用 | 18,277,135.85 | 117,346,017.34 | 85,171,399.2 | 55,475,820.01 |
| 研发费用 | 5,061,333.88 | 27,798,790.45 | 13,816,597.37 | 7,772,598.65 |
| 财务费用 | -230,314.65 | 791,628.67 | 1,252,780.95 | 872,037.64 |
| 其中:利息费用 | 990,622.36 | 6,979,225.42 | 5,481,854.12 | 5,650,847.31 |
| 其中:利息收入 | 1,274,037.7 | 6,371,352.31 | 3,726,193.16 | 4,234,243.11 |
| 加:投资收益 | - | -1,158,671.77 | - | - |
| 资产处置收益 | - | 5,887.66 | - | - |
| 资产减值损失(新) | 2,079,646.01 | -19,890,121.15 | -7,910,298.38 | -9,503,218.73 |
| 信用减值损失(新) | 399,498.41 | 2,358,651.67 | 7,129,286.02 | 6,815,035.39 |
| 其他收益 | 1,068,348.49 | 3,687,075.54 | 1,370,473.33 | 857,958.29 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 54,629,088.11 | 78,440,237.7 | 65,000,552.83 | 46,658,175.27 |
| 加:营业外收入 | 25,681.83 | 2,110,311.11 | - | 108,133.01 |
| 减:营业外支出 | 1,251,750.65 | 6,260,317.16 | 1,786,440.81 | 1,354,290.11 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 53,403,019.29 | 74,290,231.65 | 63,214,112.02 | 45,412,018.17 |
| 减:所得税费用 | 9,367,411.02 | 29,936,643.48 | 17,104,421.37 | 13,686,594.15 |
| 六、净利润 | 44,035,608.27 | 44,353,588.17 | 46,109,690.65 | 31,725,424.02 |
| 持续经营净利润 | 44,035,608.27 | 44,353,588.17 | 46,109,690.65 | 31,725,424.02 |
| 归属于母公司股东的净利润 | 44,046,906.13 | 44,356,578.25 | 46,149,010.21 | 31,750,299.56 |
| 少数股东损益 | -11,297.86 | -2,990.08 | -39,319.56 | -24,875.54 |
| (一)基本每股收益 | 0.07 | 0.07 | 0.08 | 0.05 |
| (二)稀释每股收益 | 0.07 | 0.07 | 0.08 | 0.05 |
| 九、综合收益总额 | 44,035,608.27 | 44,353,588.17 | 46,109,690.65 | 31,725,424.02 |
| 归属于母公司股东的综合收益总额 | 44,046,906.13 | 44,356,578.25 | 46,149,010.21 | 31,750,299.56 |
| 归属于少数股东的综合收益总额 | -11,297.86 | -2,990.08 | -39,319.56 | -24,875.54 |
| 公告日期 | 2024-04-26 | 2024-04-26 | 2023-10-27 | 2023-08-25 |
| 审计意见(境内) | | 标准无保留意见 | | |